**Patent: In-house bispecific multi-chain control cloning**

| Plasmid | Short description | Long description | Cloned? |
| :---- | :---- | :---- | :---- |
| P\_2061 | L1-L2-OptoL2 (Epcoritamab) | pB-cHS4x1 SV40-pA CMVp-full CMV-intron-A EpcLC1- WPRE bGH-pA CMVp-full CMV-intron-A IgK-sp\_EpcLC2- WPRE bGH-pA 8xTetOminCMV-full CMV-intron-A IgK-sp\_EpcLC2- WPRE bGH-pA ARS REV(cHS4x1 SV40-pA SV40p GLUL-CHO SV40early-pA)-cHS4x1-PB | Yes |
| P\_2064 | H2-H1 (Epcoritamab) | pB-cHS4x1 SV40-pA CMVp-full CMV-intron-A IgK-sp EpcHC2- WPRE bGH-pA CMVp-full CMV-intron-A IgK-sp\_EpcHC1- WPRE bGH-pA ARS REV(cHS4x1 SV40-pA SV40p PuroR-CHO SV40early-pA)-cHS4x1-PB | Yes |
| P\_2062 | L2-L1-OptoL1 (Epcoritamab) | pB-cHS4x1 SV40-pA CMVp-full CMV-intron-A IgK-sp EpcLC2- WPRE bGH-pA CMVp-full CMV-intron-A IgK-sp\_EpcLC1- WPRE bGH-pA 8xTetOminCMV-full CMV-intron-A IgK-sp\_EpcLC1- WPRE bGH-pA ARS REV(cHS4x1 SV40-pA SV40p GLUL-CHO SV40early-pA)-cHS4x1-PB | Yes |
| P\_2065 | H2-H1-L1-IRES-L2-OptoL2 (Epcoritamab)-- “All in one” | pB-cHS4x1 SV40-pA CMVp-full CMV-intron-A IgK-sp EpcHC2- WPRE bGH-pA CMVp-full CMV-intron-A IgK-sp\_EpcHC1- WPRE bGH-pA CMVp-full CMV-intron-A IgK-sp EpcLC1 \-IRES-IgK SP-EpcLC2- WPRE bGH-pA 8xTetOminCMV-full CMV-intron-A IgK-sp\_EpcLC2- WPRE bGH-pA ARS REV(cHS4x1 SV40-pA SV40p GLUL-CHO SV40early-pA)-cHS4x1-PB | Yes |

